Sexual Health in Breast Cancer Patients

University of Colorado Denver (CU Denver)

Status: Completed

Conditions: Breast Cancer

Treatments: Behavioral: Focus Group

Study type: Observational

Funder types: Other

Identifiers

NCT05138510

NCI-2021-10894 (Other Identifier)

20-1789.cc

Details and patient eligibility

About

In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment.

Full description

In the present study, we propose a mixed methods approach to characterize and address the sexual health needs among women with breast cancer at the time of diagnosis and throughout treatment. The objectives are as follows:

1. To characterize the sexual well-being of women longitudinally throughout the continuum of care, from initial diagnosis into survivorship.

   We predict that treatment will adversely affect sexual well-being, and that patient factors, clinical factors, and treatment choices will influence changes in sexual well-being.

2. To identify gaps is sexual health education provided at the time of diagnosis or during treatment and to determine the appropriate timing of sexual health education delivery.

Enrollment: 93 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with ductal carcinoma in situ or invasive breast cancer, seen in the breast center between 09/01/2019 to present, will potentially be recruited to participate.

Exclusion criteria

• Patients less than 18 years of age and those with non-cancer diagnoses or prior history of breast cancer will be excluded.

Trial design

93 participants in 5 patient groups

Stage 0

Description:

Ductal carcinoma in situ. Timing: start of endocrine therapy

Treatment:

Behavioral: Focus Group

Stages I-III Surgery first

Description:

Invasive cancer. Surgery first Timing: start of endocrine therapy

Treatment:

Behavioral: Focus Group

Stages I-III, neoadjuvant chemotherapy first

Description:

Invasive cancer. Neoadjuvant chemotherapy first Timing: during neoadjuvant chemotherapy

Treatment:

Behavioral: Focus Group

Stage IV

Description:

Metastatic cancer, chemotherapy only, no invasive surgery Timing: 2 months into treatment

Treatment:

Behavioral: Focus Group

Survivors

Description:

Timing: any time

Treatment:

Behavioral: Focus Group